Characteristics of multiple myeloma patients
Patient . | Age, y/sex . | Stage . | Status . |
---|---|---|---|
1 | 86/F | III | Relapsed refractory |
2 | 58/M | III | Relapsed |
3 | 59/F | III | Relapsed |
4 | 72/F | III | Discontinued therapy neuropathy |
5 | 56/F | III | Progression |
6 | 71/F | II | Plateau |
7 | 64/M | IIIA | Relapsed |
8 | 75/F | I | Observation only |
9 | 60/M | IIIA | Relapsed refractory |
10 | 58/M | II | Relapsed |
11 | 74/M | III | Relapsed refractory |
12 | 45/F | I | Observation only |
13 | 86/M | III | Relapsed |
Patient . | Age, y/sex . | Stage . | Status . |
---|---|---|---|
1 | 86/F | III | Relapsed refractory |
2 | 58/M | III | Relapsed |
3 | 59/F | III | Relapsed |
4 | 72/F | III | Discontinued therapy neuropathy |
5 | 56/F | III | Progression |
6 | 71/F | II | Plateau |
7 | 64/M | IIIA | Relapsed |
8 | 75/F | I | Observation only |
9 | 60/M | IIIA | Relapsed refractory |
10 | 58/M | II | Relapsed |
11 | 74/M | III | Relapsed refractory |
12 | 45/F | I | Observation only |
13 | 86/M | III | Relapsed |
Age average, 66.5 ± 12.1 years.